KR102867739B1 - 폐 투여에 의한 우울증의 치료 방법에 사용하기 위한 케타민 조성물 - Google Patents

폐 투여에 의한 우울증의 치료 방법에 사용하기 위한 케타민 조성물

Info

Publication number
KR102867739B1
KR102867739B1 KR1020217011554A KR20217011554A KR102867739B1 KR 102867739 B1 KR102867739 B1 KR 102867739B1 KR 1020217011554 A KR1020217011554 A KR 1020217011554A KR 20217011554 A KR20217011554 A KR 20217011554A KR 102867739 B1 KR102867739 B1 KR 102867739B1
Authority
KR
South Korea
Prior art keywords
composition
ketamine
delete delete
dose
esketamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217011554A
Other languages
English (en)
Korean (ko)
Other versions
KR20210068465A (ko
Inventor
마치에 비에초렉
실비아 야노브스카
Original Assignee
셀론 파르마 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 셀론 파르마 에스.에이. filed Critical 셀론 파르마 에스.에이.
Publication of KR20210068465A publication Critical patent/KR20210068465A/ko
Application granted granted Critical
Publication of KR102867739B1 publication Critical patent/KR102867739B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020217011554A 2018-09-28 2019-09-24 폐 투여에 의한 우울증의 치료 방법에 사용하기 위한 케타민 조성물 Active KR102867739B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18461615.9 2018-09-28
EP18461615.9A EP3628313B1 (en) 2018-09-28 2018-09-28 Ketamine composition for use in a method of treatment of depression by pulmonary administration
PCT/EP2019/075735 WO2020064748A1 (en) 2018-09-28 2019-09-24 Ketamine composition for use in a method of treatment of depression by pulmonary administration

Publications (2)

Publication Number Publication Date
KR20210068465A KR20210068465A (ko) 2021-06-09
KR102867739B1 true KR102867739B1 (ko) 2025-10-13

Family

ID=63713806

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217011554A Active KR102867739B1 (ko) 2018-09-28 2019-09-24 폐 투여에 의한 우울증의 치료 방법에 사용하기 위한 케타민 조성물

Country Status (14)

Country Link
US (1) US11925607B2 (https=)
EP (3) EP3628313B1 (https=)
JP (1) JP7444864B2 (https=)
KR (1) KR102867739B1 (https=)
CN (1) CN113038941A (https=)
AU (1) AU2019349624B2 (https=)
BR (1) BR112021005687A2 (https=)
CA (1) CA3114325A1 (https=)
EA (1) EA202190724A1 (https=)
ES (2) ES3021221T3 (https=)
HU (2) HUE071303T2 (https=)
MX (1) MX2021003668A (https=)
PL (2) PL3628313T3 (https=)
WO (1) WO2020064748A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3505157T3 (pl) 2017-12-29 2022-04-11 Celon Pharma S.A. Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
GB0523031D0 (en) * 2005-11-11 2005-12-21 Yaupon Therapeutics Enhancement of morphine analgesia by s(-)-norketamine
WO2007111880A2 (en) 2006-03-22 2007-10-04 Mount Sinai School Of Medicine Intranasal administration of ketamine to treat depression
DE102007009888A1 (de) 2007-02-28 2008-09-04 Hermann, Holger Lars, Dr. Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
PE20141906A1 (es) 2012-03-12 2014-12-05 Janssen Pharmaceutica Nv Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento
WO2014020155A1 (en) 2012-08-02 2014-02-06 Clinpharm Reform Gmbh Oral transmucosal adminstration forms of s-ketamine
PE20200404A1 (es) 2013-03-15 2020-02-26 Janssen Pharmaceutica Nv Composicion farmaceutica de clorhidrato de s-ketamina
CN116251084A (zh) 2013-03-15 2023-06-13 詹森药业有限公司 S-盐酸氯胺酮的药物组合物
CN106714789A (zh) * 2014-08-13 2017-05-24 詹森药业有限公司 用于治疗抑郁症的方法
US20160338977A1 (en) * 2015-05-20 2016-11-24 Janssen Pharmaceutica Nv Methods and kits for treating depression
CN106562952B (zh) * 2015-10-09 2020-06-09 江阴安博生物医药有限公司 氯胺酮在治疗重性抑郁障碍中的应用
PL3505157T3 (pl) * 2017-12-29 2022-04-11 Celon Pharma S.A. Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie

Also Published As

Publication number Publication date
PL3628313T3 (pl) 2025-06-23
JP2022502429A (ja) 2022-01-11
HUE071649T2 (hu) 2025-09-28
EP3628313A1 (en) 2020-04-01
EP3856159A1 (en) 2021-08-04
MX2021003668A (es) 2021-08-19
EP4578505A3 (en) 2025-09-03
US11925607B2 (en) 2024-03-12
EP3856159B1 (en) 2025-03-12
ES3021221T3 (en) 2025-05-26
EA202190724A1 (ru) 2021-08-18
KR20210068465A (ko) 2021-06-09
HUE071303T2 (hu) 2025-08-28
AU2019349624B2 (en) 2025-08-28
PL3856159T3 (pl) 2025-06-16
EP3856159C0 (en) 2025-03-12
US20210353560A1 (en) 2021-11-18
BR112021005687A2 (pt) 2021-06-22
ES3028459T3 (en) 2025-06-19
EP3628313B1 (en) 2025-02-12
CA3114325A1 (en) 2020-04-02
EP4578505A2 (en) 2025-07-02
EP3628313C0 (en) 2025-02-12
JP7444864B2 (ja) 2024-03-06
WO2020064748A1 (en) 2020-04-02
AU2019349624A1 (en) 2021-04-29
CN113038941A (zh) 2021-06-25

Similar Documents

Publication Publication Date Title
US12440440B2 (en) Dry powder esketamine composition for use in the treatment of bipolar depression by pulmonary administration
ES2775606T3 (es) Furoato de fluticasona en el tratamiento de la EPOC
CN107205936B (zh) 包含至少一种通过喷雾干燥得到的增加制剂稳定性的干粉的组合物
UA119774C2 (uk) Комбінації формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл)
KR102867739B1 (ko) 폐 투여에 의한 우울증의 치료 방법에 사용하기 위한 케타민 조성물
EA044969B1 (ru) Композиция кетамина для применения в способе лечения депрессии путём ингаляционного введения
EA046690B1 (ru) Композиция кетамина в виде сухого порошка для применения при лечении депрессии ингаляционным путем
CN119486717A (zh) 治疗肺疾病的方法和组合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

R14 Transfer of ownership recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R14-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)